ADVFN - Advanced Financial Network.
HOME» NYSE » A » ABT Stock Price » ABT Stock News

Abbott Labs Share News

 Abbott Laboratories Stock Price
ABT Stock Price
 Abbott Laboratories Stock Chart
ABT Stock Chart
 Abbott Laboratories Stock News
ABT Stock News
 Abbott Laboratories Company Information
ABT Company Information
 Abbott Laboratories Stock Trades
ABT Stock Trades

Abbott Laboratories Executive: Planning to Grow Nutrition Business in India

By Rumman Ahmed BANGALORE--Abbott Laboratories (ABT) is looking at having a fully integrated business model to grow its nutrition business in India, where it has plans to add local manufacturing as well as sales and distribution functions to its research and development capabilities, a senior executive said Monday. Abbott Monday inaugurated its first nutrition research and development center in the South Asian nation through a tie-up with a unit of Indian biotechnology company Biocon Ltd. (532523.BY). "India is a growth area for us. We have research now. To be fully integrated, we will have everything from research to manufacturing to sales (in India)," John Landgraf, executive vice president of Abbott's global nutrition business, said in an interview. Mr. Landgraf didn't elaborate on Abbott's plans for setting up local manufacturing operations, but said it is the "next phase" of the company's programs for the nutrition business in India. Abbott had last month unveiled its collaboration with Syngene International Ltd., Biocon's contract research unit, to develop nutrition products targeting those afflicted by malnutrition and diabetes in the South Asian nation. Write to Rumman Ahmed in Bangalore at rumman.ahmed@dowjones.com

Stock News for Abbott Labs (ABT)
DateTimeHeadline
09/28/201617:06:44Statement of Changes in Beneficial Ownership (4)
09/28/201609:00:00Abbott Receives FDA Approval for the FreeStyle Libre Pro™ System, a...
09/27/201606:02:29Notice of Effectiveness (effect)
09/26/201613:46:24Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)
09/21/201614:00:00Malnutrition Adds $15.5 Billion Annually to Direct U.S. Medical...
09/21/201610:37:00Abbott Laboratories to Delist from London Stock Exchange
09/21/201609:00:00Abbott Hosts Conference Call for Third-Quarter Earnings
09/20/201616:59:49Registration Statement for Securities to Be Issued in Business...
09/20/201609:00:00Fueling Performance with Fat: EAS® Launches First Ketogenic...
09/17/201603:02:00J&J to Buy Abbott Eye Business -- WSJ
09/16/201618:26:00J&J to Buy Abbott's Eye-Surgery Unit for $4.325 billion -- 3rd...
09/16/201617:55:00J&J to Buy Abbott's Eye-Surgery Unit for $4.325 billion -- 2nd...
09/16/201617:03:04Current Report Filing (8-k)
09/16/201615:59:00J&J to Buy Abbott's Eye-Surgery Unit for $4.325 billion -- Update
09/16/201615:00:00Abbott to Sell Abbott Medical Optics to Johnson & Johnson for...
09/16/201613:20:00J&J Nears Deal to Buy Abbott's Eye-Surgery Unit
09/16/201613:07:00J&J Nears Deal to buy Abbott's Eye-Surgery Equipment Unit
09/15/201609:00:00Abbott Declares 371st Consecutive Quarterly Dividend
09/13/201617:26:56Registration Statement for Securities to Be Issued in Business...
09/08/201613:11:00Abbott Named Industry Leader for Responsible and Sustainable...

Abbott Laboratories and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad